Neuronetics, Inc.
$1.58
▲
2.01%
2026-04-21 09:38:00
neurostar.com/neuronetics
NGM: STIM
Explore Neuronetics, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$109.46 M
Current Price
$1.58
52W High / Low
$4.85 / $0.8
Stock P/E
—
Book Value
$0.32
Dividend Yield
—
ROCE
-28.31%
ROE
-1.35%
Face Value
—
EPS
$-0.59
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
658
Beta
0.87
Debt / Equity
344.14
Current Ratio
2.02
Quick Ratio
1.87
Forward P/E
-4.22
Price / Sales
0.63
Enterprise Value
$159.55 M
EV / EBITDA
-5.77
EV / Revenue
1.07
Rating
Buy
Target Price
$4.33
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 2. | Enovis Corporation | $26.27 | — | $1.52 B | — | -0.58% | -58.27% | $37.85 / $21 | $26.05 |
| 3. | IRADIMED CORPORATION | $92.93 | 52.96 | $1.19 B | 0.76% | 26.52% | 24.78% | $107.9 / $50 | $7.4 |
| 4. | Inspire Medical Systems, Inc. | $56.97 | 11.28 | $1.64 B | — | 6.28% | 19.77% | $163.35 / $48.3 | $27.33 |
| 5. | Stryker Corporation | $334.05 | 39.78 | $127.84 B | 1.04% | 12.63% | 15.08% | $404.87 / $319.32 | $58.61 |
| 6. | Biomerica, Inc. | $2.18 | — | $6.74 M | — | -122.16% | -84.3% | $4.6 / $1.87 | $1.5 |
| 7. | Autonomix Medical, Inc. | $0.4 | — | $4.63 M | — | -143.08% | -1.89% | $2.82 / $0.34 | $0.75 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 41.78 M | 37.3 M | 38.11 M | 31.98 M | 22.49 M | — |
| Operating Profit | -5.04 M | -7.32 M | -8.06 M | -11.01 M | -11.47 M | — |
| Net Profit | -7.16 M | -9.04 M | -10.12 M | -12.68 M | -12.66 M | — |
| EPS in Rs | -0.1 | -0.13 | -0.15 | -0.18 | -0.18 | -0.44 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 149.16 M | 74.89 M | 71.35 M | 65.21 M |
| Operating Profit | -31.44 M | -34.56 M | -30.55 M | -35.11 M |
| Net Profit | -39 M | -43.71 M | -30.19 M | -37.16 M |
| EPS in Rs | -0.56 | -0.63 | -0.43 | -0.53 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 141.55 M | 140.9 M | 115.83 M | 116.88 M |
| Total Liabilities | 115.31 M | 109.1 M | 81.64 M | 59.82 M |
| Equity | 22.38 M | 27.71 M | 34.19 M | 57.06 M |
| Current Assets | 61.55 M | 58.12 M | 93.79 M | 98.77 M |
| Current Liabilities | 30.52 M | 31.27 M | 19.81 M | 33.2 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | -20.37 M | -31 M | -32.04 M | -30.74 M |
| Investing CF | -0.8 M | -2.41 M | -1.32 M | 6.73 M |
| Financing CF | 35.85 M | -6.81 M | 22.7 M | 0.21 M |
| Free CF | -21.18 M | -32.46 M | -34.41 M | -34.01 M |
| Capex | -0.8 M | -1.47 M | -2.37 M | -3.27 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 4.96% | 9.42% | — | — |
| Earnings Growth % | -44.78% | 18.76% | — | — |
| Profit Margin % | -58.36% | -42.31% | -56.99% | — |
| Operating Margin % | -46.15% | -42.82% | -53.85% | — |
| Gross Margin % | 72.32% | 72.47% | 76.26% | — |
| EBITDA Margin % | -46.96% | -32.74% | -49.01% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.